Related Experiment Video
Updated: May 24, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with
Asli Ertekin1, James M Aramini, Paolo Rossi
1Center for Advanced Biotechnology and Medicine and Northeast Structural Genomics Consortium, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA.
Abstract:
CDK2AP1 (cyclin-dependent kinase 2-associated protein 1), corresponding to the gene doc-1 (deleted in oral cancer 1), is a tumor suppressor protein. The doc-1 gene is absent or down-regulated in hamster oral cancer cells and in many other cancer cell types. The ubiquitously expressed CDK2AP1 protein is the only known specific inhibitor of CDK2, making it an important component of cell cycle regulation during G(1)-to-S phase transition. Here, we report the solution structure of CDK2AP1 by combined methods of solution state NMR and amide hydrogen/deuterium exchange measurements with mass spectrometry. The homodimeric structure of CDK2AP1 includes an intrinsically disordered 60-residue N-terminal region and a four-helix bundle dimeric structure with reduced Cys-105 in the C-terminal region. The Cys-105 residues are, however, poised for disulfide bond formation. CDK2AP1 is phosphorylated at a conserved Ser-46 site in the N-terminal "intrinsically disordered" region by IκB kinase ε.
Insights
Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) functions as a tumor suppressor and cell cycle regulator. Its solution structure reveals an intrinsically disordered N-terminal region and a four-helix bundle, crucial for its function.
Area of Science:
- Structural Biology
- Molecular Biology
- Cancer Research
Background:
- CDK2AP1 (deleted in oral cancer 1) is a tumor suppressor protein involved in cell cycle regulation.
- Its absence or downregulation is observed in various cancer types, highlighting its significance.
- CDK2AP1 is the sole known specific inhibitor of CDK2, critical for the G1-to-S phase transition.
Purpose of the Study:
- To determine the solution structure of CDK2AP1.
- To elucidate the structural basis of CDK2AP1's function in cell cycle regulation and tumor suppression.
Main Methods:
- Solution Nuclear Magnetic Resonance (NMR) spectroscopy.
- Amide hydrogen/deuterium exchange measurements coupled with mass spectrometry.
Main Results:
- The homodimeric structure of CDK2AP1 was elucidated.
- It features an intrinsically disordered N-terminal region (60 residues) and a C-terminal four-helix bundle.
- Cys-105 residues are positioned for potential disulfide bond formation, and Ser-46 is phosphorylated by IκB kinase ε.
Conclusions:
- The determined structure provides insights into CDK2AP1's mechanism as a cell cycle regulator and tumor suppressor.
- The intrinsically disordered region and specific phosphorylation site are key features for its biological activity.
- Structural understanding may facilitate the development of targeted cancer therapies.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Related Concept Videos
Anaphase Promoting Complex
Anaphase Promoting Complex
Positive Regulator Molecules
Positive Regulator Molecules
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...